Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael J. McNamara
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal
Frontiers in Oncology
Cancer Research
Oncology
Related publications
Preparative Immunotherapy With Anti-Ox40 and Anti-Ctla4 Improves the Response to Chemotherapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-Treated Mice
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Putting the Brakes on BTLA in T Cell–mediated Cancer Immunotherapy
Journal of Clinical Investigation
Medicine
Combination Immunotherapy for Melanoma
JAMA Oncology
Cancer Research
Oncology
The Future of Cancer Treatment: Immunomodulation, CARs and Combination Immunotherapy
Nature Reviews Clinical Oncology
Oncology
Triple Combination Immunotherapy With GVAX, Anti-Pd-1 Monoclonal Antibody, and Agonist Anti-Ox40 Monoclonal Antibody Is Highly Effective Against Murine Intracranial Glioma
OncoImmunology
Oncology
Allergy
Immunology
Novel Non-Nucleotidic STING Agonists for Cancer Immunotherapy
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
MS21.06 Immunotherapy - Sequence or Combination?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck
Archives of Otolaryngology–Head & Neck Surgery
